Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301
Yuhan Corporation
Byoung Chul Cho; Myung-Ju Ahn; Jin Hyoung Kang; Ross A Soo; Thanyanan Reungwetwattana; James Chih-Hsin Yang; Irfan Cicin; Dong-Wan Kim; Yi-Long Wu; Shun Lu; Ki Hyeong Lee; Yong-Kek Pang; Anastasia Zimina; Chin Heng Fong; Elena Poddubskaya; Ahmet Sezer; Soon Hin How; Pongwut Danchaivijitr; YuKyung Kim; Yeji Lim; Taewon An; Hana Lee; Hae Mi Byun; Bojan Zaric